征稿进行中丨肿瘤/免疫/mRNA/AI等生命科学前沿研究专题开放投稿（含APC优惠）

Core Insights - The article discusses the launch of the Game Changer Series by Taylor & Francis and Dove Medical Press, aimed at soliciting groundbreaking research in life sciences and medicine that focuses on mechanism breakthroughs, technological innovations, and translational value [2][3]. Group 1: Research Focus Areas - The series emphasizes research in cutting-edge areas such as tumor biology, immune mechanisms, and novel drug and technology platforms [3]. - Key submission topics include antibody-drug conjugates (ADC) for breast cancer treatment, CAR-T cell therapy, immune checkpoint inhibitors for hepatocellular carcinoma, and BTK inhibitors for hematological malignancies [6][7]. - Additional areas of interest are personalized antimicrobial strategies, AI-driven drug resistance prediction, fecal microbiota transplantation, and HPV vaccines [7]. Group 2: Immune, Inflammation, and Biologics - The series also focuses on immune pathways, precision targeting, and new strategies in biological therapies [9]. - Specific topics include anti-inflammatory biologics for chronic inflammation, targeting the IL-4/IL-13 axis in type 2 inflammation treatment, and personalized biologic therapies for asthma [11]. Group 3: Advanced Technologies and Rare Diseases - The transformative applications of lipid nanoparticles in mRNA therapeutics and the role of AI in healthcare risk management are highlighted as significant advancements [15]. - The series aims to spotlight breakthroughs in rare disease treatments, emphasizing precision medicine [15]. Group 4: Target Audience - The call for submissions is directed at researchers in life sciences, medicine, biotechnology, drug development, and translational research who focus on mechanism innovation and technological breakthroughs [16].